128 related articles for article (PubMed ID: 37063051)
1. Is the use of IVF add-on treatments driven by patients or clinics? Findings from a UK patient survey.
Cirkovic S; Wilkinson J; Lensen S; Jackson E; Harper J; Lindemann K; Costa-Font J
Hum Fertil (Camb); 2023 Dec; 26(2):365-372. PubMed ID: 37063051
[TBL] [Abstract][Full Text] [Related]
2. How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients.
Lensen S; Hammarberg K; Polyakov A; Wilkinson J; Whyte S; Peate M; Hickey M
Hum Reprod; 2021 Jun; 36(7):1854-1861. PubMed ID: 33942073
[TBL] [Abstract][Full Text] [Related]
3. VALUE study: a protocol for a qualitative semi-structured interview study of IVF add-ons use by patients, clinicians and embryologists in the UK and Australia.
Armstrong SC; Lensen S; Vaughan E; Wainwright E; Peate M; Balen AH; Farquhar CM; Pacey A
BMJ Open; 2021 May; 11(5):e047307. PubMed ID: 34020980
[TBL] [Abstract][Full Text] [Related]
4. The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites.
van de Wiel L; Wilkinson J; Athanasiou P; Harper J
Reprod Biomed Online; 2020 Nov; 41(5):801-806. PubMed ID: 32888824
[TBL] [Abstract][Full Text] [Related]
5. Passion, pressure and pragmatism: how fertility clinic medical directors view IVF add-ons.
Iacoponi O; van de Wiel L; Wilkinson J; Harper JC
Reprod Biomed Online; 2022 Jul; 45(1):169-179. PubMed ID: 35537928
[TBL] [Abstract][Full Text] [Related]
6. IVF add-ons in Australia and New Zealand: A systematic assessment of IVF clinic websites.
Lensen S; Chen S; Goodman L; Rombauts L; Farquhar C; Hammarberg K
Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):430-438. PubMed ID: 33594674
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of add-ons: selected IVF "add-on" procedures and future directions.
Glatthorn HN; Decherney A
J Assist Reprod Genet; 2022 Mar; 39(3):581-589. PubMed ID: 35066700
[TBL] [Abstract][Full Text] [Related]
8. In vitro fertilization add-ons for the endometrium: it doesn't add-up.
Lensen S; Shreeve N; Barnhart KT; Gibreel A; Ng EHY; Moffett A
Fertil Steril; 2019 Dec; 112(6):987-993. PubMed ID: 31843098
[TBL] [Abstract][Full Text] [Related]
9. Ethics and IVF add-ons: We need to talk about it.
Braga DPAF; Setti AS; Borges E
JBRA Assist Reprod; 2022 Aug; 26(3):371-373. PubMed ID: 35930629
[TBL] [Abstract][Full Text] [Related]
10. The crafting of hope: Contextualising add-ons in the treatment trajectories of IVF patients.
Perrotta M; Hamper J
Soc Sci Med; 2021 Oct; 287():114317. PubMed ID: 34492406
[TBL] [Abstract][Full Text] [Related]
11. "Add-Ons" for Assisted Reproductive Technology: Do Patients Get Honest Information from Fertility Clinics' Websites?
Galiano V; Orvieto R; Machtinger R; Nahum R; Garzia E; Sulpizio P; Marconi AM; Seidman D
Reprod Sci; 2021 Dec; 28(12):3466-3472. PubMed ID: 33939166
[TBL] [Abstract][Full Text] [Related]
12. Patient and professional perspectives about using in vitro fertilisation add-ons in the UK and Australia: a qualitative study.
Armstrong SC; Vaughan E; Lensen S; Caughey L; Farquhar CM; Pacey A; Balen AH; Peate M; Wainwright E
BMJ Open; 2023 Jul; 13(7):e069146. PubMed ID: 37495387
[TBL] [Abstract][Full Text] [Related]
13. Endometrial scratching for subfertility: everyone's doing it.
Lensen S; Sadler L; Farquhar C
Hum Reprod; 2016 Jun; 31(6):1241-4. PubMed ID: 27008891
[TBL] [Abstract][Full Text] [Related]
14. Surveys of clinician and patient attitudes to an add-on for in vitro fertilisation.
Anderson K; Blaxall M; Lensen S; Farquhar C
Aust N Z J Obstet Gynaecol; 2022 Oct; 62(5):761-766. PubMed ID: 35726738
[TBL] [Abstract][Full Text] [Related]
15. A Baby at All Costs? Exploring the Use and Provision of Unproven Adjuvant Treatments in the Context of IVF.
Jones GL; Lang V; Hudson N
Semin Reprod Med; 2021 Nov; 39(5-06):220-226. PubMed ID: 34500475
[TBL] [Abstract][Full Text] [Related]
16. Is it ethical to provide IVF add-ons when there is no evidence of a benefit if the patient requests it?
Zemyarska MS
J Med Ethics; 2019 May; 45(5):346-350. PubMed ID: 30745435
[TBL] [Abstract][Full Text] [Related]
17. Endometrial scratching in Australia, New Zealand and the United Kingdom (UK): a follow-up survey.
Sarwari M; Beilby K; Hammarberg K; Hickey M; Lensen S
Hum Fertil (Camb); 2023 Jul; 26(3):599-604. PubMed ID: 34905720
[TBL] [Abstract][Full Text] [Related]
18. Discussing the possibility of fertility treatment being unsuccessful as part of routine care offered at clinics: patients' experiences, willingness, and preferences.
Sousa-Leite M; Costa R; Figueiredo B; Gameiro S
Hum Reprod; 2023 Jul; 38(7):1332-1344. PubMed ID: 37196325
[TBL] [Abstract][Full Text] [Related]
19. Analysis of fertility clinic marketing of complementary therapy add-ons.
Stein J; Harper JC
Reprod Biomed Soc Online; 2021 Aug; 13():24-36. PubMed ID: 34141907
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of endometrial scratching before the second IVF/ICSI treatment: a cost-effectiveness analysis of a randomized controlled trial (SCRaTCH trial).
van Hoogenhuijze NE; van Eekelen R; Mol F; Schipper I; Groenewoud ER; Traas MAF; Janssen CAH; Teklenburg G; de Bruin JP; van Oppenraaij RHF; Maas JWM; Moll E; Fleischer K; van Hooff MHA; de Koning CH; Cantineau AEP; Lambalk CB; Verberg M; van Heusden AM; Manger AP; van Rumste MME; van der Voet LF; Pieterse QD; Visser J; Brinkhuis EA; den Hartog JE; Glas MW; Klijn NF; van der Zanden M; Bandell ML; Boxmeer JC; van Disseldorp J; Smeenk J; van Wely M; Eijkemans MJC; Torrance HL; Broekmans FJM
Hum Reprod; 2022 Jan; 37(2):254-263. PubMed ID: 34864993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
